Skip to content

Advertisement

Gut Pathogens

Open Access

Existence of a novel qepA variant in quinolone resistant Escherichia coli from aquatic habitats of Bangladesh

  • Zillur Rahman1,
  • Aminul Islam1,
  • Mahamud-ur Rashid1,
  • Fatema-Tuz Johura1,
  • Shirajum Monira1,
  • Haruo Watanabe2,
  • Niyaz Ahmed1,
  • Andrew Camilli3 and
  • Munirul Alam1Email author
Contributed equally
Gut Pathogens20179:58

https://doi.org/10.1186/s13099-017-0207-8

Received: 19 July 2017

Accepted: 10 October 2017

Published: 23 October 2017

Abstract

Of 19 environmental Escherichia coli (n = 12) and Klebsiella pneumoniae (n = 7) tested for quinolone resistance-related genes qnrA, qnrB, qnrC, qnrS and qepA, four each of E. coli and K. pneumoniae possessed qnrS, and another E. coli isolate possessed a new variant of qepA. This is the first detection of qepA in environmentally dwelling bacteria in Bangladesh.

Keywords

Novel qepA variant qepA4 Quinolone resistance Escherichia coli Bangladesh

Background

Acquisition of resistance towards several classes of antibiotics and the spread of multi-drug resistant bacteria is of immense public health concern globally. Increased use of quinolones, a family of synthetic chemical agents and one of the most commonly prescribed broad-spectrum antimicrobials, in recent years have coincided with the increasing incidence of resistance to this drug among Enterobacteriaceae. For years, quinolone resistance was believed to be solely chromosomally mediated through nucleotide substitutions in the quinolone resistance-determining region of DNA gyrase (gyrA and gyrB) and topoisomerase IV (parC and parE), which are the main target molecules of the quinolones [1]. However, plasmid-mediated quinolone resistance (PMQR) was subsequently discovered. The PMQR gene, qnrA (currently qnrA1), encoding a protein that protects type II topoisomerases from quinolones, was first reported in 1998 [2]. Thereafter, as many as six Qnr families, named Qnr A, B, C, D, S and VC, were identified [3]. Another reported mechanism of PMQR is the covalent modification of certain quinolones including ciprofloxacin by a plasmid-encoded variant of aminoglycoside acetyltransferase AAC (6′)-Ib-cr [4]. A third mechanism of PMQR known since 2007 is efflux of quinolones by the efflux pump-encoding genes, qepA and oqxAB [5, 6].

QepA was found to be associated with decreasing susceptibility, and 8 to 32-fold increase of minimal inhibitory concentration values of the hydrophilic quinolones such as norfloxacin, ciprofloxacin and enrofloxacin [5]. So far, three variants of qepA named qepA1, qepA2 and qepA3 have been reported [5, 7, 8]. Although PMQR determinants confer a low-level of resistance to quinolones, they provide a favorable background for the selection of additional chromosome-encoded quinolone resistance mechanisms, which make clinical therapy more difficult [9]. All of these PMQR determinants are increasingly being identified worldwide in members of the Enterobacteriaceae. Since aquatic environment serves as a reservoir for diverse microbial populations including bacteria carrying PMQR determinants [13], selection pressure from residual antibiotics might facilitate horizontal transfer of these quinolone resistance genes to pathogenic bacteria. The present study was designed to investigate the presence of quinolone resistance related genes qnrA, qnrB, qnrC, qnrS and qepA in members of the family Enterobacteriaceae, namely E. coli and K. pneumoniae, isolated from a lake and a river of Dhaka city, Bangladesh. Both bacteria demonstrated frequent presence of qnrS, and one of the E. coli isolates possessed a new sequence variant of qepA designated as qepA4.

Methods

Twelve E. coli and seven K. pneumoniae were isolated from water samples collected from a lake and a river of Dhaka city. After preliminary identification by standard culturing methods, all isolates were confirmed using API 20 E (bioMérieux, France) strips. Antimicrobial susceptibility was determined by the Kirby-Bauer disk diffusion method according to the Clinical Laboratory Standards Institute recommendations. Commercially available antibiotic discs (Oxoid) of nalidixic acid (30 µg), ciprofloxacin (5 µg) and levofloxacin (5 µg) were used in the antibiotic susceptibility assay. Bacterial DNA was obtained from all isolates by the standard boiling method. Detection of PMQR genes (qnrC, qepA, qnrA, qnrB, qnrS and rmtB) was performed by polymerase chain reaction (PCR) using the primers as described elsewhere [10, 11]. In addition we designed three pair of primers.

(F1-CCTGAATGCGGATGGGTGT, R1-TGTCCAGGATCCAGAGAAGC;

F2-GCGTGTTGCTGGAGTTCTTC, R2-GCTGAATTCGGACACCGTCT;

F3-TGTTCACCATCGGCAACGA, R3-CACCTTCACCAAGACCACG; all listed 5′–3′) targeting different regions of qepA to get the full sequence (1536 bp) using overlapping PCR amplicons. The amplified fragments of qepA were then sequenced using an ABI PRISM BigDye Terminator Cycle Sequencing Reaction kit (Applied Biosystems) on an ABI PRISM 310 automated sequencer (Applied Biosystems). The deduced full length sequence of the gene was submitted to GenBank (Accession Number KX580704).

Results and discussion

Nearly half of the isolates in the present study were found to be resistant to quinolone antibiotics such as nalidixic acid (52.6%), ciprofloxacin (47.4%), and levofloxacin (47.4%). Among the 19 isolates, ten were resistant to at least one of the tested quinolones. Of the remaining nine isolates, four showed intermediate resistance to nalidixic acid, while one of the ten quinolone-resistant isolates exhibited intermediate resistance to levofloxacin. As quinolones are broad-spectrum antibiotics, people use them for wide ranging infections in Bangladesh. Morgan et al. [12] reported a frequency of 86% non-prescriptional antibiotic use in Bangladesh. Our data are suggestive of evolutionary response to this indiscriminate use of quinolones in the form of an alarmingly high incidence of quinolone resistance among the members of the family Enterobacteriaceae.

All the isolates (n = 19) were screened for PMQR genes by PCR. Of these, four each of E. coli and K. pneumoniae possessed qnrS, while another E. coli isolate possessed qepA. Unlike our study, most of the previous studies were based on clinical isolates and the most frequent PMQR gene hitherto identified has been qnrB [9]. However, this gene was not detected in any of the bacteria tested in our study. Also, none of the other two PMQR genes, qnrA and qnrC, were found in any of the isolates tested here. Five isolates carrying qnrS were found sensitive to all three quinolone antibiotics tested. Although strains carrying this gene did not exhibit resistance to the tested quinolone drugs, it is possible that qnrS might play a role in the resistance to other quinolones. Nonetheless, an environmental reservoir for the quinolone resistance related genes was demonstrated in the present study, supporting the results of an earlier study [13], which would allow horizontal transfer of gene(s) responsible for resistance to quinolone antibiotics.

QepA, a recently identified PMQR gene encoding an efflux pump [5], was detected in one of the E. coli isolates resistant to all three quinolone antibiotics tested in the present study. To our knowledge, this is the first time in Bangladesh that a qepA gene was found from environmentally occurring bacteria belonging to the family Enterobacteriaceae. The association of qepA with the rmtB gene contributing to high level resistance to aminoglycosides was reported from Belgium, China and Japan [5, 14, 15]. Previous studies on E. coli showed an association of qepA and rmtB with a composite transposable element flanked by two copies of IS26 [5]. In our study, the E. coli isolate possessing qepA did not have rmtB, as confirmed by PCR. This result suggests the possibility of independent emergence of E. coli harboring qepA locally in the aquatic environment, and possibly of different ancestry from the ones carrying qepA and rmtB, as reported from other countries [5, 14].

In the present study, DNA sequencing of qepA revealed the gene to be different from the three alleles of qepA (qepA1, qepA2 and qepA3) that have been reported so far [5, 7, 8]. Comparison of the 1536 bp DNA sequence of qepA (Accession Number KX580704) revealed eight nucleotide differences that result in eight amino acid substitutions in the deduced 511 bp amino acid sequence (Fig. 1). Thus, this qepA gene from environmental E. coli isolate E1F represents a new variant of the gene, and was designated qepA4. A phylogenetic tree constructed by the neighbor joining method (MEGA 6.0) revealed separation of qepA4 from all qepA alleles reported so far, although it is most closely related to the qepA2 branch (Fig. 2). This result, combined with the absence of a linked rmtB gene noted above, suggests a different lineage for E. coli carrying qepA found in Bangladesh. This novel variant of a quinolone resistance determinant and the presence of other PMQR genes in naturally disseminating Enterobacteriaceae call for urgent surveillance to monitor and prevent the spread of these resistant bacteria in vulnerable populations of Bangladesh.
Fig. 1

CLUSTAL W alignment of QepA1, QepA2, QepA3 and QepA4 from isolate E1F. Dot (.) indicates identical sequences

Fig. 2

Phylogenetic tree constructed by the neighbour-joining method by MEGA 6.0 based on the qepA gene isolated from different locations worldwide. Numbers at the tip of branches denote the bootstrap percentages for 1000 replicates. Evolutionary distance of the nucleotide substitutions per site is indicated by the scale

Notes

Declarations

Authors’ contributions

ZR, AI and MA participated in the conception and design of the study. ZR, AI and MR performed the laboratory work. ZR, AI and MA analyzed the data and wrote the manuscript. MR, FJ, SM, HW, NA and AC contributed to the analysis and helped in writing the manuscript. All authors read and approved the final manuscript.

Acknowledgements

icddr,b acknowledges the following donors: the governments of Bangladesh, Canada, Sweden and United Kingdom for providing core/unrestricted support.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

Data sharing not applicable to this article.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.

Funding

This research study was supported jointly by icddr,b and the National Institutes of Infectious Diseases (NIID), Japan.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
International Center for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
(2)
Department of Bacteriology, National Institute of Infectious Diseases, Tokyo, Japan
(3)
Department of Molecular Biology and Microbiology, Howard Hughes Medical Institute, Tufts University School of Medicine, Boston, USA

References

  1. Hooper DC. Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis. 2001;7(2):337–41.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Martinez-Martinez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet. 1998;351(9105):797–9.View ArticlePubMedGoogle Scholar
  3. Jacoby G, Cattoir V, Hooper D, Martinez-Martinez L, Nordmann P, Pascual A, Poirel L, Wang M. qnr Gene nomenclature. Antimicrob Agents Chemother. 2008;52(7):2297–9.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, Park CH, Bush K, Hooper DC. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med. 2006;12(1):83–8.View ArticlePubMedGoogle Scholar
  5. Yamane K, Wachino J, Suzuki S, Kimura K, Shibata N, Kato H, Shibayama K, Konda T, Arakawa Y. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother. 2007;51(9):3354–60.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Hansen LH, Jensen LB, Sorensen HI, Sorensen SJ. Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria. J Antimicrob Chemother. 2007;60(1):145–7.View ArticlePubMedGoogle Scholar
  7. Cattoir V, Poirel L, Nordmann P. Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France. Antimicrob Agents Chemother. 2008;52(10):3801–4.View ArticlePubMedPubMed CentralGoogle Scholar
  8. Wang D, Huang X, Chen J, Mou Y, Li H, Yang L. Characterization of genetic structures of the QepA3 gene in clinical isolates of Enterobacteriaceae. Front Microbiol. 2015;6:1147.PubMedPubMed CentralGoogle Scholar
  9. Jacoby GA, Strahilevitz J, Hooper DC. Plasmid-mediated quinolone resistance. Microbiol Spectr. 2014. doi:10.1128/microbiolspec.PLAS-0006-2013.PubMedPubMed CentralGoogle Scholar
  10. Kim HB, Park CH, Kim CJ, Kim EC, Jacoby GA, Hooper DC. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother. 2009;53(2):639–45.View ArticlePubMedGoogle Scholar
  11. Yan JJ, Wu JJ, Ko WC, Tsai SH, Chuang CL, Wu HM, Lu YJ, Li JD. Plasmid-mediated 16S rRNA methylases conferring high-level aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae isolates from two Taiwanese hospitals. J Antimicrob Chemother. 2004;54(6):1007–12.View ArticlePubMedGoogle Scholar
  12. Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S. Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis. 2011;11(9):692–701.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Poirel L, Cattoir V, Nordmann P. Plasmid-mediated quinolone resistance; interactions between human, animal, and environmental ecologies. Front Microbiol. 2012;3:24.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Perichon B, Courvalin P, Galimand M. Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli. Antimicrob Agents Chemother. 2007;51(7):2464–9.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Deng Y, Zeng Z, Chen S, He L, Liu Y, Wu C, Chen Z, Yao Q, Hou J, Yang T, et al. Dissemination of IncFII plasmids carrying rmtB and qepA in Escherichia coli from pigs, farm workers and the environment. Clin Microbiol Infect. 2011;17(11):1740–5.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s) 2017

Advertisement